Skip to content

Investment Watch Blog

We provide unfiltered news and market signals for people who have no time to search.

  • Home
  • About
  • Subscribe
    • Monthly Subscription
    • 6-Month Subscription
    • Yearly Subscription
  • Member’s Area
    • Member Hub
    • Login
    • Account
  • Privacy Policy
  • Disclaimer

The FDA has approved Neuralink launching its first human clinical study. What could possibly go wrong?!

May 25, 2023, 7:59 PM by Alex Mark
Share this story

https://t.co/hCJc20GyM1

— PiQ (@PiQMarkets) May 25, 2023

h/t CJGAussie

2 views
Categories On Wire
US action on short-sellers likely in ‘next few months’ -DOJ official
New Ridesharing App: Like Uber, But With Guns
Donate

Trending

Categories

  • Advertorial
  • Market Signals
  • Off Script
  • On Wire

Recent Posts

  • ‘Global reckoning for big tech’: Australia to force social media platforms to allow users to opt out of algorithms
  • Houthis strike Saudi Aramco refinery.
  • Woman saves her dogs from mama moose in Big Sky (video).
  • Rick Santelli is retiring next month — This is one of his all time greatest hits.
  • Pilot shot down over Iran will speak with 60 Minutes.
© 2026 Investment Watch Blog • Built with GeneratePress